An outbreak of multi-resistant Serratia marcescens involving 24 patients oc
curred in a bone marrow transplant and oncology unit, from September 1998 t
o June 1999, of whom 14 developed serious infection. This is the first such
outbreak described in a BMT unit. All isolates demonstrated the same antim
icrobial susceptibility pattern and were the same unusual serotype O21:K14,
The antimicrobial susceptibility profile showed reduced susceptibility to
ciprofloxacin, gentamicin and piperacillin-tazobactam. As the latter two an
timicrobials are part of our empiric therapy for febrile neutropenia, they
were substituted with meropenem and amikacin during the outbreak. Investiga
tion revealed breaches in infection control practices. Subsequently, the ou
tbreak was contained following implementation of strict infection control m
easures, A prominent feature of the outbreak was prolonged carriage in some
patients. These patients may have acted as reservoirs for cross-infection.
This report also indicates that patients who become colonised with Serrati
a marcescens may subsequently develop invasive infection during neutropenic
periods.